Literature DB >> 6871551

Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.

V Csik, L Szekeres, E Udvary.   

Abstract

1 The effects of verapamil (0.15/kg) and fendiline (3 mg/kg) were studied in anaesthetized, thoracotomised dogs with a critical constriction of the left anterior descending coronary artery, paced in excess of the initial rate by 60-70 beats/min. Epicardial ST-segment elevation and changes in lactate uptake were used to assess the severity of myocardial ischaemia. 2 Both drugs prevented the ST-segment elevation and the reduced lactate uptake that resulted from atrial pacing. 3 The anti-ischaemic effect of fendiline is mainly due to its negative chronotropic action, whereas that of verapamil is due in part to bradycardia and in part to the reduced preload and afterload. In addition, both agents increase coronary flow to the ischaemic area and thus improve the myocardial oxygen supply/oxygen requirement ratio.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871551      PMCID: PMC2044837          DOI: 10.1111/j.1476-5381.1983.tb10492.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  [Drug therapy of coronary heart disease (author's transl)].

Authors:  M Kaltenbach
Journal:  Arzneimittelforschung       Date:  1977

2.  Effects of verapamil on regional myocardial blood flow and ST segment. Role of the induced bradycardia.

Authors:  A Berdeaux; R Coutte; J Giudicelli; J Boissier
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

3.  Inotropic effects of Nifedipine: a new coronary dilating agent.

Authors:  B E Strauer
Journal:  Int J Clin Pharmacol       Date:  1974-03

4.  Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion.

Authors:  P L da Luz; L F Monteiro de Barros; J J Leite; F Pileggi; L V Décourt
Journal:  Am J Cardiol       Date:  1980-02       Impact factor: 2.778

5.  Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men.

Authors:  J H Atterhög; L G Ekelund
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

6.  The effect of beta-adrenoceptor blocking drugs on free fatty acid and glucose utilization of the isolated canine heart with normal and restricted flow in the presence and absence of noradrenaline.

Authors:  L Szekeres; V Csik; E Udvary
Journal:  Acta Biol Med Ger       Date:  1978

7.  Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.

Authors:  L Szekeres; V Csik; E Udvary
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

8.  Antianginal and myocardial metabolic properties of verapamil in coronary artery disease.

Authors:  J Ferlinz; M E Turbow
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

9.  Effect of intravenous verapamil on exercise tolerance and left ventricular function in patients with severe exertional angina pectoris.

Authors:  P Carlens
Journal:  J Cardiovasc Pharmacol       Date:  1981 Jan-Feb       Impact factor: 3.105

10.  Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise.

Authors:  V B Subramanian; A Lahiri; R Paramasivan; E B Raftery
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

View more
  1 in total

1.  Nicardipine in models of myocardial infarction.

Authors:  B J Alps; C Calder; A Wilson
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.